For many years, The Centers for Medicare and Medicaid Services (CMS) have had in place two (2) regulations (F 309 & 329) for long-term care facilities to assess, evaluate, and attempt gradual dose reductions in the use of antipsychotic, antianxiety, and hypnotic/sedative medications. In 2012, CMS challenged long-term and skilled care communities to reduce the use of these medications by 15%. The overall challenge from CMS was to improve dementia care, with one (1)focus being the reduction of antipsychotics in addition to implementation of other key principles in dementia care. These goals are challenging nursing facilities to develop new care approaches for residents and medication review processes.

Hampton, J.K., Reiter, T., Doerr, J., & Popejoy, L. (2014). Using FOCUS PDA to improve antipsychotic medication management. Journal of Nursing Care Quality, 29(4), 295-302.